Endometrial cancer education tool development
Part of Cancer, Women’s health & pregnancy clinical trials.
This study is developing an educational tool to help women with endometrial cancer understand their diagnosis and treatment. It involves giving feedback on the tool and testing it during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman diagnosed with endometrial cancer.
- You are at least 18 years old.
- You can read and speak English or Spanish.
- For the pilot part: you are receiving or will receive systemic treatment (like chemotherapy or immunotherapy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study talks to women about their experience with endometrial cancer or related conditions to understand what might increase risk and how to prevent it. It includes women with and without a diagnosis so researchers can compare perspectives.
This study is developing a tool to help women decide if using a hormone-releasing intrauterine device (IUD) is right for them to lower their risk of endometrial cancer. Researchers are interviewing women at different risk levels and healthcare providers to make the tool useful and easy to understand.
This study tests a multimedia tool designed to help people with ovarian or endometrial cancer understand and decide about genetic testing. The tool may make it easier to learn about genetic testing options and make informed choices.
This study looks at how well a surgical tool is used during standard surgery for early endometrial cancer, and whether it relates to test results from fluid taken in the abdomen. It may help surgeons improve how samples are collected and interpreted during routine care.
This study tests a digital tool called MyCareGorithm that helps patients understand their cancer treatment plans. It is for people with head and neck or prostate cancer, their caregivers, and their doctors.
This study tests a Spanish-language decision tool to help people with advanced ovarian cancer choose the best maintenance therapy after chemotherapy. It is for patients who can read or speak Spanish and are eligible for maintenance treatment.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.